Evaluation of Seroconversion Rate Following Sars Cov 2 Vaccination in Health Care Workers at Shahid Beheshti University of Medical Sciences Publisher



Alavi M¹ ; Mousavi M² ; Jazayeri M³ ; Ebadifar A^{2, 4} Show Affiliations
Source: Avicenna Journal of Medical Biotechnology Published:2023

Abstract

Background: Vaccines are the most effective way to prevent Coronavirus 2 severe acute respiratory syndrome (SARS-CoV-2). This study examines and compares the effi-ciency of AstraZeneca, Sinopharm, and Sputnik vaccines and the correlation of antibody response with age, sex, and history of corona disease in employees of Shahid Be-heshti University of Medical Sciences. Methods: 202 participants were included, of which 82 were administered the Astra-Zeneca, 59 were given the Sinopharm, and 61 were given the Sputnik vaccine. SARS-CoV-2 IgM and IgG antibody levels were checked four weeks after passing the second dose of all three vaccines using the enzyme-linked immunosorbent assay (ELISA) tech-nique. Results: There was no significant difference between the amount of IgM and IgG antibodies among three vaccines (p=0.056). For all three vaccines, gender and age did not significantly affect the amount of IgM and IgG antibodies. The history of infection with COVID-19 increased the antibody response (p>0.5). Conclusion: The titer of IgM and IgG antibodies were not statistically significantly dif-ferent. The IgM and IgG antibodies produced by vector-based vaccines are higher than the Sinopharm vaccine. Gender did not affect the produced antibody titer. No significant linear relationship was found between age and antibody titer. In people from this study who received two doses of the AstraZeneca vaccine and had a corona history, the aver-age amount of both IgM and IgG antibodies was measured more than the other partici-pants. © 2023, Avicenna Journal of Medical Biotechnology. All rights reserved.